4//SEC Filing
ENDOCYTE INC 4
Accession 0001144204-16-079688
CIK 0001235007operating
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 8:47 PM ET
Size
10.8 KB
Accession
0001144204-16-079688
Insider Transaction Report
Form 4
ENDOCYTE INCECYT
Ellis P Ron
DirectorPresident and CEO
Transactions
- Tax Payment
Common Stock
2016-02-04$3.18/sh−3,320$10,558→ 333,036 total - Tax Payment
Common Stock
2016-02-06$3.02/sh−2,085$6,297→ 330,951 total - Award
Stock Option (right to buy)
2016-02-04+161,250→ 161,250 totalExercise: $3.18Exp: 2026-02-04→ Common Stock (161,250 underlying) - Award
Common Stock
2016-02-04+26,875→ 336,356 total
Footnotes (5)
- [F1]Represents restricted stock units that will vest and be paid 1/4 annually over a period of 4 years beginning on February 4, 2017, in the form of one share of common stock for each restricted stock unit.
- [F2]Includes 2,617 and 1,668 shares acquired under the Endocyte, Inc. 2010 Employee Stock Purchase Plan on June 15, 2015 and December 15, 2015, respectively.
- [F3]Represents shares withheld to satisfy tax withholding obligations associated with the settlement of 8,959 restricted stock units in the form of Company common stock on a one-for-one basis on February 4, 2016.
- [F4]Represents shares withheld to satisfy tax withholding obligations associated with the settlement of 5,625 restricted stock units in the form of Company common stock on a one-for-one basis on February 6, 2016.
- [F5]Shares subject to the option vest 1/4 annually over a period of 4 years beginning on February 4, 2017.
Documents
Issuer
ENDOCYTE INC
CIK 0001235007
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001235007
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 8:47 PM ET
- Size
- 10.8 KB